Epigenetic drug screen of CD20-low expressing cell line revealed possible treatment target.

KOZLOVÁ, Veronika, Aneta LEDEREROVÁ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michal ŠMÍDA. Epigenetic drug screen of CD20-low expressing cell line revealed possible treatment target. In Joint retreat 2019, Kouty u Ledče nad Sázavou. 2019.

Basic information

Original name

Epigenetic drug screen of CD20-low expressing cell line revealed possible treatment target.

Authors

KOZLOVÁ, Veronika, Aneta LEDEREROVÁ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michal ŠMÍDA

Edition

Joint retreat 2019, Kouty u Ledče nad Sázavou, 2019

---

Other information

Type of outcome

Conference abstract

Confidentiality degree

is not subject to a state or trade secret

Organization unit

Central European Institute of Technology

---

Links

LQ1601, research and development project	Name: CEITEC 2020 (Acronym: CEITEC2020) Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1105/2018, interní kód MU	Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit VI (Acronym: VýDiTeHeMA VI) Investor: Masaryk University, Category A